Responses
Drug information (i. anti-infectives, ii. cytostatics, iii. others)
DGI-020 Cost and Effectiveness of Targeted Treatment with Cetuximab or Bevacizumab as Maintenance Treatment in Patients with Colorectal Cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.